The Aurora extravascular implantable cardioverter defibrillator and the Epsila extravascular lead earned a CE mark supported by results from a global pivotal study.

Establishing partnerships with external collaborators is a key part of pharmaceutical companies’ growth strategies – but identifying the right candidates for these partnerships before competitors remains a challenge.